NOACs vs. Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation

Atrial fibrillation is a heart arrhythmia associated with increased risk for ischemic stroke. Vitamin K antagonists were developed to decrease a patient's clotting risk; however, these medications require therapeutic monitoring and have several drug interactions. Novel oral anticoagulants (NOAC...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Priya, Pandya, Jheel, Goldberg, Madeline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2017
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572042/
https://www.ncbi.nlm.nih.gov/pubmed/28845374
http://dx.doi.org/10.7759/cureus.1395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572042/
https://www.ncbi.nlm.nih.gov/pubmed/28845374
http://dx.doi.org/10.7759/cureus.1395

Ejemplares similares